Glaxo to Maintain Swine-Flu Shipments as Demand Falters

Glaxo to Maintain Swine-Flu Shipments as Demand Falters

online.wsj.com

BY MARIETTA CAUCHI
LONDON -- U.K. pharmaceuticals giant GlaxoSmithKline PLC said Friday that swine-flu shipments, coupled with other pandemic vaccine products supplied to the U.S. and other governments in the three months ended Dec. 30, amounted to provisional sales of £835 million ($1.36 billion).

The world's second-biggest drug maker shipped 130 million H1N1 flu shots to governments in the fourth quarter of 2009, and said that it would continue to keep up ...

(visit the link for the full news article)

BY MARIETTA CAUCHI
LONDON -- U.K. pharmaceuticals giant GlaxoSmithKline PLC said Friday that swine-flu shipments, coupled with other pandemic vaccine products supplied to the U.S. and other governments in the three months ended Dec. 30, amounted to provisional sales of £835 million ($1.36 billion).

The world's second-biggest drug maker shipped 130 million H1N1 flu shots to governments in the fourth quarter of 2009.




online.wsj.com
(visit the link for the full news article)

Mod Note: You Have An Urgent U2U- Click Here.